LIDDS AB is a drug delivery company based on the proprietary technology NanoZolid, which formulate drugs for local and intratumoral administration. The company was founded on November 4, 1999 and is headquartered in Uppsala, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company